New diabetes pill elecoglipron faces final test in 600-Patient trial
NCT ID NCT07664553
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 study tests whether a new oral drug called elecoglipron can help adults with type 2 diabetes better manage their blood sugar when added to their current insulin and other diabetes medications. About 600 participants will receive either elecoglipron or a placebo daily for 40 weeks. The main goal is to see if elecoglipron lowers HbA1c (a measure of average blood sugar) more than placebo.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Elecoglipron (oral drug)
What this could lead to
If successful, elecoglipron could offer a new daily pill to help people with type 2 diabetes better control their blood sugar when insulin alone isn't enough.
What could go wrong
This is a phase 3 trial, but results are not yet available. The drug may not prove more effective than placebo, and side effects are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Little Rock, Arkansas, 72205, United States
-
Research Site
Lincoln, California, 95648, United States
-
Research Site
Aurora, Colorado, 80045, United States
-
Research Site
Ocoee, Florida, 34761, United States
-
Research Site
Decatur, Georgia, 30030, United States
-
Research Site
Potomac, Maryland, 20854, United States
-
Research Site
Cary, North Carolina, 27518, United States
-
Research Site
Morehead City, North Carolina, 28557, United States
-
Research Site
Myrtle Beach, South Carolina, 29572, United States
-
Research Site
Memphis, Tennessee, 38119, United States
-
Research Site
Houston, Texas, 77040, United States
-
Research Site
San Antonio, Texas, 78231, United States
-
Research Site
Renton, Washington, 98057, United States
-
Research Site
East Toowoomba, 4350, Australia
-
Research Site
Parkville, 3050, Australia
-
Research Site
St Leonards, 2065, Australia
-
Research Site
Dupnitsa, 2600, Bulgaria
-
Research Site
Kozloduy, 3320, Bulgaria
-
Research Site
Plovdiv, 4001, Bulgaria
-
Research Site
Sofia, 1618, Bulgaria
-
Research Site
Stara Zagora, 6000, Bulgaria
-
Research Site
Veliko Tarnovo, 5000, Bulgaria
-
Research Site
Yambol, 8600, Bulgaria
-
Research Site
Surrey, British Columbia, V3T 4G8, Canada
-
Research Site
Vancouver, British Columbia, V5Y 3W2, Canada
-
Research Site
Sarnia, Ontario, N7T 4X3, Canada
-
Research Site
Scarborough Village, Ontario, M1R 0B1, Canada
-
Research Site
Toronto, Ontario, M4G3E8, Canada
-
Research Site
Saint-Charles-Borromée, Quebec, J6E 2B4, Canada
-
Research Site
Changsha, 410013, China
-
Research Site
Changsha, 410015, China
-
Research Site
Hefei, 230000, China
-
Research Site
Hefei, 230601, China
-
Research Site
Huai'an, 223005, China
-
Research Site
Langfang, 065000, China
-
Research Site
Liangyugang, 222002, China
-
Research Site
Luoyang, 471009, China
-
Research Site
Nanjing, 2100008, China
-
Research Site
Nanyang, 473009, China
-
Research Site
Pinggu, 101200, China
-
Research Site
Pingxiang, 337055, China
-
Research Site
Shijiazhuang, 050000, China
-
Research Site
Tianjin, 300134, China
-
Research Site
Yueyang, 414000, China
-
Research Site
Broumov, 55001, Czechia
-
Research Site
České Budějovice, 370 01, Czechia
-
Research Site
Ostrava, 710 00, Czechia
-
Research Site
Pilsen, 301 00, Czechia
-
Research Site
Prague, 140 00, Czechia
-
Research Site
Prague, 170 00, Czechia
-
Research Site
Prague, 181 00, Czechia
-
Research Site
Amberg, 92224, Germany
-
Research Site
Bad Oeynhausen, 32545, Germany
-
Research Site
Berlin, 13597, Germany
-
Research Site
Bochum, 44869, Germany
-
Research Site
Brandenburg an der Havel, 14776, Germany
-
Research Site
Daaden, 57567, Germany
-
Research Site
Duisburg, 47051, Germany
-
Research Site
Eisenach, 99817, Germany
-
Research Site
Elsterwerda, 04910, Germany
-
Research Site
Falkensee, 14612, Germany
-
Research Site
Frankfurt, 60596, Germany
-
Research Site
Fulda, 36037, Germany
-
Research Site
Gladbeck, 45968, Germany
-
Research Site
Hamburg, 22607, Germany
-
Research Site
Hannoversch Münden, 34346, Germany
-
Research Site
Magdeburg, 39120, Germany
-
Research Site
Mannheim, 68167, Germany
-
Research Site
Münster, 48153, Germany
-
Research Site
Nittendorf, 93152, Germany
-
Research Site
Obertshausen, 63179, Germany
-
Research Site
Oldenburg, 23758, Germany
-
Research Site
Pirna, 01796, Germany
-
Research Site
Bangalore, 560 092, India
-
Research Site
Belagavi, 590006, India
-
Research Site
Chennai, 600086, India
-
Research Site
Coimbatore, 641018, India
-
Research Site
Guntur, 522001, India
-
Research Site
Hyderabad, 500034, India
-
Research Site
Indore, 452008, India
-
Research Site
Kochi, 682041, India
-
Research Site
Madurai, 625020, India
-
Research Site
Mumbai, 400012, India
-
Research Site
New Delhi, 110029, India
-
Research Site
Pune, 411021, India
-
Research Site
Asahikawa-shi, 070-8530, Japan
-
Research Site
Kashiwa-shi, 277-0825, Japan
-
Research Site
Komoro, 384-8588, Japan
-
Research Site
Kyoto, 606-8507, Japan
-
Research Site
Miyazaki, 880-0034, Japan
-
Research Site
Naka, 311-0113, Japan
-
Research Site
Yokohama, 230-8765, Japan
-
Research Site
Batu Caves, 68100, Malaysia
-
Research Site
Kuala Lumpur, 59100, Malaysia
-
Research Site
Miri, 98000, Malaysia
-
Research Site
Putrajaya, 62250, Malaysia
-
Research Site
Seremban, 70300, Malaysia
-
Research Site
Bialystok, 15-897, Poland
-
Research Site
Częstochowa, 42-217, Poland
-
Research Site
Kielce, 25-355, Poland
-
Research Site
Krakow, 31-261, Poland
-
Research Site
Lodz, 90-338, Poland
-
Research Site
Poznan, 60-354, Poland
-
Research Site
Radom, 26-600, Poland
-
Research Site
Warsaw, 00-124, Poland
-
Research Site
Warsaw, 02-507, Poland
-
Research Site
Bucheon-si, 14647, South Korea
-
Research Site
Gyeonggi-do, 13620, South Korea
-
Research Site
Jongno-gu, 110-746, South Korea
-
Research Site
Junggu, 22332, South Korea
-
Research Site
Seoul, 03080, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 06591, South Korea
-
Research Site
Seoul, 5505, South Korea
-
Research Site
Bangkok, 10330, Thailand
-
Research Site
Bangkok, 10400, Thailand
-
Research Site
Bangkok, 10700, Thailand
-
Research Site
Hat Yai, 90110, Thailand
-
Research Site
Muang, 50200, Thailand
-
Research Site
Mueang, 20000, Thailand